Loring Wolcott & Coolidge Fiduciary Advisors LLP Merck & Co., Inc. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q2 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 379,060 shares of MRK stock, worth $30.1 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
379,060
Previous 393,674
3.71%
Holding current value
$30.1 Million
Previous $35.3 Million
15.08%
% of portfolio
0.27%
Previous 0.34%
Shares
34 transactions
Others Institutions Holding MRK
# of Institutions
3,874Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.1 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.57 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.49 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.74 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $201B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...